title: Ventriculo-peritoneal shunt infection due to non-equi Rhodococcus sp.
authors.forename: Jaime
authors.initials: J
authors.lastname: Lora-Tamayo
authors.forename: Nuria
authors.initials: N
authors.lastname: Fernández-Sabé
authors.forename: Pedro F
authors.initials: PF
authors.lastname: Viladrich
authors.forename: Ricard
authors.initials: R
authors.lastname: Verdaguer
authors.forename: Andreu
authors.initials: A
authors.lastname: Gabarrós
mesh_terms: D000193:Actinomycetales Infections / Q000175:diagnosis*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012240:Rhodococcus / Q000302:isolation & purification*; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use; D017287:Ventriculoperitoneal Shunt / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002442:Ceftazidime